Conflict of Interest Guidelines Revised at the National Institute of Health

The amount of money considered to constitute a conflict of interest has been lowered at the National Institute of Health.

The 16 year old conflict of interest rules for medical researchers has been revised, expanding the required disclosures.

Concern about the integrity of research in the United States has grown since 2008, when Iowa Republican Sen. Charles Grassley criticized prominent Harvard University psychiatrist Dr. Joseph Biederman and others for failing to fully disclose payments from drug companies.

In a more recent example, medical device maker Medtronic Inc came under fire over accusations that doctors paid by the company had failed to disclose major side effects from a bone growth drug in clinical trials.

Private sector funds have no place in policy governing the health of the nation.

Related Posts

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>